Head and Neck Paragangliomas: Value of Contrast-Enhanced 3D MR Angiography

References

1. ↵
   Rao AB, Koeller KK, Adair CF. From the archives of the AFIP: paragangliomas of the head and neck—radiologic-pathologic correlation. Armed Forces Institute of Pathology. Radiographics 1999;19:1605–32

   PubMedWeb of Science
2. ↵
   Lustrin ES, Palestro C, Vaheesan K. Radiographic evaluation and assessment of paragangliomas. Otolaryngol Clin North Am 2001;34:881–906, vi

   CrossRefPubMedWeb of Science
3. ↵
   Noujaim SE, Pattekar MA, Cacciarelli A, et al. Paraganglioma of the temporal bone: role of magnetic resonance imaging versus computed tomography. Top Magn Reson Imaging 2000;11:108–22

   CrossRefPubMed
4. ↵
   Ross MR, Schomer DF, Chappell P, et al. MR imaging of head and neck tumors: comparison of T1-weighted contrast-enhanced fat-suppressed images with conventional T2-weighted and fast spin-echo T2-weighted images. AJR Am J Roentgenol 1994;163:173–78

   PubMedWeb of Science
5. ↵
   Mafee MF, Raofi B, Kumar A, et al. Glomus faciale, glomus jugulare, glomus tympanicum, glomus vagale, carotid body tumors, and simulating lesions: role of MR imaging. Radiol Clin North Am 2000;38:1059–76

   CrossRefPubMedWeb of Science
6. ↵
   Larson TC 3rd, Reese DF, McDonald TJ, et al. Glomus tympanicum chemodectomas: radiographic and clinical characteristics. Radiology 1987;163:801–06

   PubMedWeb of Science
7. ↵
   Lo WW, Solti-Bohman LG, Lambert PR. High-resolution CT in the evaluation of glomus tumors of the temporal bone. Radiology 1984;150:737–42

   PubMedWeb of Science
8. ↵
   Lewin JS, Curtin HD, Ross JS, et al. Fast spin-echo imaging of the neck: comparison with conventional spin-echo, utility of fat suppression, and evaluation of tissue contrast characteristics. AJNR Am J Neuroradiol 1994;15:1351–57

   Abstract/FREE Full Text
9. ↵
   Vogl TJ, Juergens M, Balzer JO, et al. Glomus tumors of the skull base: combined use of MR angiography and spin-echo imaging. Radiology 1994;192:103–10

   PubMed
10. ↵
    Caldemeyer KS, Mathews VP, Azzarelli B, et al. The jugular foramen: a review of anatomy, masses, and imaging characteristics. Radiographics 1997;17:1123–39

    PubMed
11. ↵
    Heiserman JE, Dean BL, Hodak JA, et al. Neurologic complications of cerebral angiography. AJNR Am J Neuroradiol 1994;15:1401–07, discussion 1408–11

    Abstract/FREE Full Text
12. ↵
    Arnold SM, Strecker R, Scheffler K, et al. Dynamic contrast enhancement of paragangliomas of the head and neck: evaluation with time-resolved 2D MR projection angiography. Eur Radiol 2003;13:1608–11

    CrossRefPubMed
13. ↵
    Vogl TJ, Mack MG, Juergens M, et al. Skull base tumors: gadodiamide injection–enhanced MR imaging—drop-out effect in the early enhancement pattern of paragangliomas versus different tumors. Radiology 1993;188:339–46

    PubMedWeb of Science
14. ↵
    DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837–45

    CrossRefPubMedWeb of Science
15. ↵
    Nagele T, Petersen D, Klose U, et al. Dynamic contrast enhancement of intracranial tumors with snapshot-FLASH MR imaging. AJNR Am J Neuroradiol 1993;14:89–98

    Abstract/FREE Full Text
16. ↵
    Wutke R, Lang W, Fellner C, et al. High-resolution, contrast-enhanced magnetic resonance angiography with elliptical centric k-space ordering of supra-aortic arteries compared with selective X-ray angiography. Stroke 2002;33:1522–29

    Abstract/FREE Full Text
17. ↵
    Yoshikawa T, Aoki S, Hori M, et al. Time-resolved two-dimensional thick-slice magnetic resonance digital subtraction angiography in assessing brain tumors. Eur Radiol 2000;10:736–44

    CrossRefPubMed
18. ↵
    van den Berg R, Verbist BM, Mertens BJ, et al. Head and neck paragangliomas: improved tumor detection using contrast-enhanced 3D time-of-flight MR angiography as compared with fat-suppressed MR imaging techniques. AJNR Am J Neuroradiol 2004;25:863–70

    Abstract/FREE Full Text
19. ↵
    van den Berg R. Imaging and management of head and neck paragangliomas. Eur Radiol 2005;15:1310–18

    CrossRefPubMed
20. ↵
    Duet M, Sauvaget E, Petelle B, et al. Clinical impact of somatostatin receptor scintigraphy in the management of paragangliomas of the head and neck. J Nucl Med 2003;44:1767–74

    Abstract/FREE Full Text
21. ↵
    Kwekkeboom DJ, van Urk H, Pauw BK, et al. Octreotide scintigraphy for the detection of paragangliomas. J Nucl Med 1993;34:873–78

    Abstract/FREE Full Text
22. ↵
    Olsen WL, Dillon WP, Kelly WM, et al. MR imaging of paragangliomas. AJR Am J Roentgenol 1987;148:201–04

    PubMedWeb of Science
23. ↵
    Bustillo A, Telischi F, Weed D, et al. Octreotide scintigraphy in the head and neck. Laryngoscope. 2004;114:434–40

    CrossRefPubMed
24. ↵
    Whiteman ML, Serafini AN, Telischi FF, et al. ¹¹¹In octreotide scintigraphy in the evaluation of head and neck lesions. AJNR Am J Neuroradiol 1997;18:1073–80

    Abstract
25. ↵
    Neumann HP, Pawlu C, Peczkowska M, et al. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 2004;292:943–51. Erratum in: JAMA 2004;292:1686

    CrossRefPubMedWeb of Science
26. ↵
    Gimenez-Roqueplo AP, Favier J, Rustin P, et al. The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. Am J Hum Genet 2001;69:1186–97

    CrossRefPubMedWeb of Science
27. ↵
    Dundee P, Clancy B, Wagstaff S, et al. Paraganglioma: the role of genetic counselling and radiological screening. J Clin Neurosci 2005;12:464–66

    CrossRefPubMed